Active Pharmaceutical Ingredients


Sr Product Name Therapeutic Classification US DMF Number Assigned CEP Number Specification
1 Aripiprazolw
29722-12-9
Antipsychotic - - EP
2 Benzocainw
4-09-7
Anesthetic 024523 December 15, 2010 - EP,USP
3 Bisacodyw
03-50-9
Laxative 20476 April 24, 2007 R0-CEP 2007-163-Rev 00 IP,BP,EP,USP
4 Bosentaw
47536-97-8
Antihypertensive - - IN HOUSE
5 Bupivacaine Hydrochloridw
4252-80-3
Anesthetic 20959 October 18, 2007 R0-CEP 2009-038- Rev 00 EP,USP
6 Cetrizine Dihydrochloridw
3881-51-0
Antihistamine 26179 June 26, 2012 Under evaluation EP,USP
7 Cinacalcet Dihydrochloridw
26256-56-0
Antihyerparathyroidism Will be submitted soon - IN HOUSE
8 Esomeprazole Magnesium Trihydratw
19141-88-7
Antiulcer - - IN HOUSE
9 Etofenamatw
0544-47-9
Anti-inflammatory - Under evaluation EP
10 Fenofibratw
9562-28-9
Antihyperlipidemia - R0-CEP 2011-092-Rev 00 EP,USP
11 Glimepiridw
3479-97-1
Antidiabetic 23005 July 27, 2009 R0-CEP 2009-176-Rev 00 EP,USP
12 Indapamidw
6807-65-8
Diuretic 22388 January 6, 2009 R0-CEP 2008-163-Rev 00 EP,USP
13 Lidocaine Hydrochloridw
37-58-6
Anesthetic - - EP,USP
14 Milnacipran Hydrochloridw
2623-85-3
Antidepressant - - IN HOUSE
15 Omeprazole Powdew
3590-58-6
Antiulcer 23219 October 20, 2009 R0-CEP 2009-298-Rev 02 EP,USP
16 Pantoprazole Sodium Sesquihydratw
38786-67-1
Antiulcer 24313 October 18, 2010 R0-CEP 2010-295-Rev 00 EP,USP
17 Picosulfate Sodiuw
0040-45-6
Laxative Under submission - EP
18 Pralidoxime Chloridw
1-15-0
Cholinesterase reactivation 21307 February 4, 2008 - USP
19 Pralidoxime Iodidw
4-63-3
Cholinesterase reactivation - - IN HOUSE
20 Quetiapine Hemifumaratw
11974-69-7
Antipsychotic 024761 March 7, 2011 - EP ,USP
21 Ropivacaine Hydrochloride (anhydrous) 84057-95-4 Anesthetic 25506 November 14, 2011 Under evaluation IN HOUSE
22 Ropivacaine Hydrochloride (monohydrate) 132112-35-7 Anesthetic 22023 September 22, 2008 - EP,USP
23 Strontium Ranelatw
35459-87-9
Osteoporosis treatment - - IN HOUSE
24 Thioridazine Hydrochloridw
0-52-2
Antipsychotic - - EP,USP
25 Topiramatw
7240-79-4
Anticonvulsant 26919 February 25, 2013 - USP
26 Tramadol Hydrochloridw
2204-88-2
Analgesic - R1-CEP 2003-148-Rev 01 EP,USP
27 Venlafaxine Hydrochloridw
3413-69-5
Antidepressant - - IN HOUSE
28 Voriconazolw
37234-62-9
Antifungal - - EP,IN HOUSE
29 Xipamidw
4293-44-8
Diuretic - - IN HOUSE

Under development at Lab / Plant Scale

Sr Product Name Therapeutic Classification
1 Agomelatinw
38112-76-2
Antidepressant
2 Atomoxetine Hydrochloridw
2248-59-7
Central Nervous system agent
3 Atovaquonw
5233-18-4
Antimalarial
4 Esomeprazole Magnesium Dihydratw
19141-88-7
Antiulcer
5 Levobupivacainw
7262-47-1
Anesthetic
6 Linozoliw
65800-03-3
Antibiotic
7 Prasugrew
50322-43-3
Platelet Inihibitor
8 Pregabaliw
48553-50-8
Anti-epileptic
9 Rabeprazole Sodiuw
17976-90-6
Proton pump inhibitor
10 Rilmenidine Dihydrogen Phosphatw
5409-38-7
Antihypertensive
11 Tolvaptaw
50683-30-0
Antihyponatremia

Under Evaluation / Research

Sr Product Name Therapeutic Classification
1 Aliskiren Fumaratw
73334-58-2
Antihypertensive
2 Aprepitanw
70729-80-3
Antiemetic
3 Eplerenonw
07724-20-9
Antihypertensive
4 Febuxostaw
44060-53-7
Anti-gout
5 Fosaprepitanw
27852-28-2
Antiemetic
6 Imidafenaciw
70105-16-5
Muscarinic receptor antagonist
7 Ivabridine Hydrochloridw
48849-67-6
Cardiovascular
8 Rocuronium bromidw
19302-91-9
Neuromuscular blocking agent
9 Sitagliptin Phosphate Monohydratw
54671-77-9
Antidiabetic
10 Vildagliptiw
74901-16-5
Antidiabetic